清热宣痹汤联合克拉霉素治疗慢性鼻窦炎肺经风热证临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R276.1

基金项目:

温州市基础科研公益项目(Y20240337)


Clinical Study on Qingre Xuanbi Decoction Combined with Clarithromycin for Chronic Rhinosinusitis with Lung Meridian Wind-Heat Syndrome
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察清热宣痹汤联合克拉霉素治疗慢性鼻窦炎(CRS) 肺经风热证的临床疗效。方法:选 择2024年1—10月在温州市中西医结合医院治疗的100例CRS肺经风热证患者,按随机数字表法分为对照组和 观察组各50例。对照组采用克拉霉素分散片治疗,观察组在对照组基础上联合清热宣痹汤治疗。2组均连续 治疗14天。比较2组临床疗效及安全性,流涕、鼻塞、发热、分泌物等症状消失时间,治疗前后血清总免疫球 蛋白E(TIgE)、嗜酸性粒细胞阳离子蛋白(ECP)、白细胞介素(IL) -6、IL-8、肿瘤坏死因子-α(TNF-α)、 鼻气道阻力(NAR)、鼻腔容积(NCV)、鼻腔最小横截面积(NMCA)。结果:治疗后,观察组总有效率 94.00%(47/50),高于对照组80.00%(40/50)(P<0.05)。观察组流涕、鼻塞、发热、分泌物等症状的消失时 间均短于对照组(P<0.05)。2组ECP、TIgE、TNF-α、IL-6、IL-8、NAR水平均较治疗前降低(P<0.05), 观察组ECP、TIgE、TNF-α、IL-6、IL-8、NAR水平均低于对照组(P<0.05);2组NCV、NMCA均较治疗前 增大(P<0.05),观察组NCV、NMCA均大于对照组(P<0.05)。2组不良反应发生率比较,差异无统计学意 义(P>0.05)。结论:清热宣痹汤联合克拉霉素治疗CRS肺经风热证效果好,能减轻炎症和变态反应,改善鼻 通气功能,缓解临床症状。

    Abstract:

    Abstract:Objective:To observe the clinical effect of Qingre Xuanbi Decoction combined with Clarithromycin on chronic rhinosinusitis (CRS) with lung meridian wind-heat syndrome. Methods:A total of 100 cases of CRS patients with lung meridian wind-heat syndrome, treated at Wenzhou Hospital of Integrated Traditional Chinese and Western Medicine from January 2024 to October 2024,were divided into the control group and the observation group according to the random number table method, with 50 cases in each group. The control group was treated with Clarithromycin Dispersible Tablets,and the observation group was treated with Qingre Xuanbi Decoction based on the treatment of the control group. Both groups were treated continuously for 14 days. Clinical effects and safety as well as the disappearance time of symptoms like rhinorrhea, rhinocleisis, fever, and nasal discharge were compared between the two groups; the levels of total immunoglobulin E (TIgE),eosinophil cationic protein ( ECP),interleukin( IL)-6,IL-8 and tumor necrosis factor- α (TNF- α) in serum, nasal airway resistance (NAR), nasal cavity volume (NCV), and nasal minimum cross-sectional area (NMCA) were compared before and after treatment. Results:After treatment,the total effective rate was 94.00% (47/50) in the observation group, higher than 80.00% (40/50) in the control group (P< 0.05). The time to resolution of symptoms such as rhinorrhea,rhinocleisis,fever,and nasal discharge was shorter in the observation group compared to the control group (P<0.05). The levels of ECP,TIgE,TNF-α,IL-6,IL-8,and NAR in the two groups were decreased when compared with those before treatment (P<0.05), with the observation group showing lower levels than the control group (P<0.05). NCV and NMCA in the two groups were increased when compared with those before treatment (P<0.05),with the observation group showing greater NCV and NMCA than the control group (P<0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P>0.05). Conclusion: Qingre Xuanbi Decoction combined with Clarithromycin is effective in treating CRS with lung meridian wind-heat syndrome, which can reduce inflammation and allergic reactions, improve nasal ventilation function,and alleviate clinical symptoms.

    参考文献
    相似文献
    引证文献
引用本文

王艳,施正贤,郑国君.清热宣痹汤联合克拉霉素治疗慢性鼻窦炎肺经风热证临床研究[J].新中医,2025,57(15):51-55

复制
相关视频

分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2025-08-11
  • 出版日期:
文章二维码